Company record
INTERVET INTERNATIONAL B.V.
- B.V.
Signals
19 on record
- EPO patentsPatent
Patent publication AU2025272056A1 by INTERVET INTERNATIONAL B.V.: MONITORING EAR TAG.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication AU2026257523A1 by INTERVET INTERNATIONAL B.V.: Caninized antibodies to human and canine CTLA-4.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication AU2026257526A1 by INTERVET INTERNATIONAL B.V.: Caninized antibodies against canine CTLA-4.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication WO2026233952A1 by INTERVET INTERNATIONAL B.V.: ATINVICINIB FOR USE IN TREATING ALLERGIC DERMATITIS IN DOGS.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication EP4827376A1 by Intervet International B.V.: TOPICAL VETERINARY PRODUCTS AND RELATED METHODS.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication EP4828621A1 by Intervet International B.V.: CRYSTALLINE FORMS OF(S)-N-(3-AMINO-1-(HYDROXYAMINO)-3-METHYL-1-OXOBUTAN-2-YL)-4- ((4-(((2-METHOXYETHYL)AMINO)METHYL)PHENYL)ETHYNYL)BENZAMIDE SALTS.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication EP4830717A2 by Intervet International B.V.: SERUM FREE INTRACELLULAR PATHOGEN VACCINE.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication EP4827908A1 by Intervet International B.V.: LOW-ENERGY ELECTRON IRRADIATION-INACTIVATED MOLLICUTES.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication EP4828614A2 by Intervet International B.V.: PROCESSES TO MAKE CRYSTALLINE FORMS OF (S)-N-(3-AMINO-1-(HYDROXYAMINO)-3-METHYL-1-OXOBUTAN-2-YL)-4-((4-(((2-METHOXYETHYL)AMINO)METHYL)PHENYL)ETHYNYL)BENZAMIDE SALTS.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication EP4827910A1 by Intervet International B.V.: A FREEZE-DRIED COMPOSITION CONTAINING LIVE ATTENUATED PATHOGENS, A PROCESS FOR PREPARING A FREEZE-DRIED COMPOSITION, A VACCINE, AND A METHOD OF VACCINATING A HOST ANIMAL.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication WO2026215241A1 by INTERVET INTERNATIONAL B.V.: ATTENUATED AFRICAN SWINE FEVER VIRUS AND USE THEREOF IN VACCINE COMPOSITIONS.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication WO2026215238A1 by INTERVET INTERNATIONAL B.V.: ATTENUATED AFRICAN SWINE FEVER VIRUS AND USE THEREOF IN VACCINE COMPOSITIONS.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication MX2026007645A by INTERVET INTERNATIONAL B.V.: TOPICAL VETERINARY PRODUCTS AND RELATED METHODS.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication MX2026009915A by INTERVET INTERNATIONAL B.V.: ORAL RESPIRATORY VACCINE.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication MX2026007741A by INTERVET INTERNATIONAL B.V.: CRYSTALLINE FORMS OF(S)-N-(3-AMINO-1-(HYDROXYAMINO)-3-METHYL-1-OXOBUTAN-2-YL)-4- ((4-(((2-METHOXYETHYL)AMINO)METHYL)PHENYL)ETHYNYL)BENZAMIDE SALTS.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication WO2026202345A1 by INTERVET INTERNATIONAL B.V.: SYNTHESIS OF CYCLOPROPYLAMIDE COMPOUNDS, ITS INTERMEDIATES AND USES.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication WO2026202344A1 by INTERVET INTERNATIONAL B.V.: SYNTHESIS OF CYCLOPROPYLAMIDE COMPOUNDS AND ITS INTERMEDIATES.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication WO2026202347A1 by INTERVET INTERNATIONAL B.V.: SYNTHESIS OF CYCLOPROPYLAMIDE COMPOUNDS, ITS INTERMEDIATES AND USES.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication WO2026202346A1 by INTERVET INTERNATIONAL B.V.: SYNTHESIS OF CYCLOPROPYLAMIDE COMPOUNDS, ITS INTERMEDIATES AND USES.
EPO patentsRelevance21
Watch · 80% confidence